Skip to main content
Log in

The microscopic anatomy of experimental rat CC531 colon tumour metastases: Consequences for immunotherapy?

  • Published:
Clinical & Experimental Metastasis Aims and scope Submit manuscript

Abstract

The colon adenocarcinoma cell line CC531 was adopted as a model for immunotherapeutical treatment of experimental colorectal metastases in a syngeneic rat model. We studied the presence and localization of T and natural killer cells, vessels and matrix proteins in in vivo growing CC531 tumours by immunohistochemistry. CC531 tumours were induced either in the lungs by injecting CC531 tumour cells into a tail vein or in the liver by injection of CC531 tumour cells under the liver capsule or into a mesenteric vein. All 3 tumour types were composed of islets of tightly apposed tumour cells surrounded by abundantly present tumour-stroma which contained tumour vessels and matrix proteins. Some of these matrix proteins, especially laminin and collagen IV formed a basal membrane-like structure around the tumour nodules. This structure was most pronounced in mesenteric vein-induced liver tumours and less prominent in subcapsular-induced liver tumours and tail vein-induced lung tumours. Tumour-infiltrating lymphocytes of both T and natural killer cell origin were found in the tumours, but predominantly in the tumour stroma, separated from the islets of tumour cells by the basal membrane-like structure. We hypothesize that the matrix proteins of these tumours play an ambivalent role: they may provide a substratum for migration of effector cells into the tumour stroma but may also provide a barrier preventing direct contact between tumour target cells and immune effector cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Basse PH, Herberman RB, Hokland ME et al. Tissue distribution of adoptively transferred adherent LAK cells: Role of the route of administration. Nat Immun 1992; 11: 193–202.

    PubMed  CAS  Google Scholar 

  2. Basse PH, Herberman RB, Nannmark U et al. Accumulation of adoptively transferred adherent, lymphokineactivated killer cells in murine metastases. J Exp Med 1991; 174: 479–88.

    Article  PubMed  CAS  Google Scholar 

  3. Beun GDM, Van de Velde CJH, Fleuren GJ et al. T cell retargeting using bispecific monoclonal antibodies in a rat colon carcinoma model. IV. Tumor neutralization in Winn type assays. J Immunother 1993; 14: 11–5.

    PubMed  CAS  Google Scholar 

  4. Beun GDM, van Eendenburg JDH, Corver WE et al. T cell retargeting using bispecific monoclonal antibodies in a rat colon carcinoma model. I. Significant bispecific lysis of syngeneic colon carcinoma CC531 is critically dependent on prolonged preactivation of effector Tlymphocytes by immobilized antiTcell receptor antibody. J Immunother 1992; 11: 238–48.

    PubMed  CAS  Google Scholar 

  5. Chambers WH, Vujanovic NL, DeLeo AB et al. Monoclonal antibody to a triggering structure expressed on rat natural killer cells and adherent lymphokineactivated killer cells. J Exp Med 1989; 169: 1373–89.

    Article  PubMed  CAS  Google Scholar 

  6. Chaux P, Moutet M, Faivre J et al. Inflammatory cells infiltrating human colorectal carcinomas express HLA class II but not B71 and B72 costimulatory molecules of the T cell activation. Lab Invest 1996; 74: 975–83.

    PubMed  CAS  Google Scholar 

  7. Csiba A, Whitwell HL, Moore M. Distribution of histocompatibility and leucocyte differentiation antigens in normal human colon and in benign and malignant colonic neoplasms. Br J Cancer. 1984; 50: 699–709.

    PubMed  CAS  Google Scholar 

  8. Duijvestijn AM, van Goor H, Klatter F et al. Antibodies defining rat endothelial cells: RECA1, a panendothelial cellspecific monoclonal antibody. Lab Invest 1992; 66: 459–66.

    PubMed  CAS  Google Scholar 

  9. Forster SJ, Talbot IC, Critchley DR. Laminin and fibronectin in rectal adenocarcinoma: Relationship to tumour grade, stage and metastasis. Br J Cancer 1984; 50: 51–61.

    PubMed  CAS  Google Scholar 

  10. Griffini P, Smorenburg SM, Verbeek FJ et al. Threedimensional reconstruction of colon carcinoma metastases in liver. J Microscopy 1997; 187: 12–21.

    Article  CAS  Google Scholar 

  11. Hagenaars M, Ensink NG, Koelemij R et al. Regional administration of natural killer cells in a rat hepatic metastasis model results in better tumor infiltration and antitumor response than systemic administration. Int J Cancer 1998; 75: 233–8.

    Article  PubMed  CAS  Google Scholar 

  12. Hagenaars M, Zwaveling S, Kuppen PJK et al. Characteristics of tumor infiltration by adoptively transferred and endogenous natural killer cells in a syngeneic rat model: Implications for the mechanism behind anti tumor responses. Int J Cancer 1998; 78: 783–9.

    Article  PubMed  CAS  Google Scholar 

  13. Havenith MG, Arends JW, Simon R et al. Type IV collagen immunoreactivity in colorectal cancer. Prognostic value of basement membrane deposition. Cancer 1988; 62: 2207–11.

    Article  PubMed  CAS  Google Scholar 

  14. Havenith MG, van Zandvoort EHM, Cleutjens JPM et al. Basement membrane deposition in benign and malignant naevomelanocytic lesions: An immunohistochemical study with antibodies to type IV collagen and laminin. Histopathology 1989; 15: 137–46.

    PubMed  CAS  Google Scholar 

  15. Hida J, Matsuda T, Kitaoka M et al. The role of basement membrane in colorectal cancer invasion and liver metastasis. Cancer 1994; 74: 592–8.

    Article  PubMed  CAS  Google Scholar 

  16. Hilders CGJM, Houbiers JGA, Van Ravenswaay Claasen HH et al. Association between HLAexpression and infiltration of immune cells in cervical carcinoma. Lab Invest 1993; 69: 651–9.

    PubMed  CAS  Google Scholar 

  17. Hünig T, Wallny HJ, Hartley JK et al. A monoclonal antibody to a constant determinant of the rat T cell antigen receptor that induces T cell activation. Differential reactivity with subsets of immature and mature T lymphocytes. J Exp Med 1989; 169: 73–86.

    Article  PubMed  Google Scholar 

  18. Johansson BR, Nannmark U. Ultrastructure of interactions between activated murine natural killer cells and melanoma cells in an extracellular matrix (Matrigel(R)) environment. Nat Immun 1996; 15: 98–106.

    PubMed  Google Scholar 

  19. Kitson RP, Appasamy PM, Nannmark U et al. Matrix metalloproteinases produced by rat IL-2-activated NK cells. J Immunol 1998; 160: 4248–53.

    PubMed  CAS  Google Scholar 

  20. Korhonen M, Laitinen L, Ylänne J et al. Integrin distribution in renal cell carcinomas of various grades of malignancy. Am J Pathol 1992; 141: 1161–71.

    PubMed  CAS  Google Scholar 

  21. Kuppen PJK, Basse PH, Goldfarb RH et al. The infiltration of experimentally induced lung metastases of colon carcinoma CC531 by adoptively transferred interleukin2activated natural killer cells in Wag rats. Int J Cancer 1994; 56: 574–9.

    PubMed  CAS  Google Scholar 

  22. Kuppen PJK, Marinelli A, Camps JAJ et al. Biodistribution of lymphokineactivated killer (LAK) cells in Wag rats after hepaticartery or jugularvein infusion. Int J Cancer 1992; 52: 266–70.

    PubMed  CAS  Google Scholar 

  23. Ljubimov AV, Bartek J, Couchman JR et al. Distribution of individual components of basement membrane in human colon polyps and adenocarcinomas as revealed by monoclonal antibodies. Int J Cancer 1992; 50: 562–6.

    PubMed  CAS  Google Scholar 

  24. Marquet RL, Westbroek DL, Jeekel J. Interferon treatment of a transplantable rat colon adenocarcinoma: Importance of tumor site. Int J Cancer 1984; 33: 689–92.

    PubMed  CAS  Google Scholar 

  25. Mukai S, Kjoergaard J, Shu S et al. Infiltration of tumors by systemically transferred tumorreactive T lymphocytes is required for antitumor efficacy. Cancer Res 1999; 59: 5245–9.

    PubMed  CAS  Google Scholar 

  26. Naito Y, Saito K, Shiiba K et al. CD8C T cells infiltrated within cancer cells nests as a prognostic factor in human colorectal cancer. Cancer Res 1998; 58: 3491–4.

    PubMed  CAS  Google Scholar 

  27. Nannmark U, Johansson BR, Bryant JL et al. Microvessel origin and distribution in pulmonary metastases of B16 melanoma: Implication for adoptive immunotherapy. Cancer Res 1995; 55: 4627–32.

    PubMed  CAS  Google Scholar 

  28. Offerhaus GJ, Giardiello FM, Bruijn JA et al. The value of immunohistochemistry for collagen IV expression in colorectal carcinomas. Cancer 1991; 67: 99–105.

    Article  PubMed  CAS  Google Scholar 

  29. Pujuguet P, Hammann A, Martin F et al. Abnormal basement membrane in tumors induced by rat colon cancer cells. Gastroenterology 1994; 107: 701–11.

    PubMed  CAS  Google Scholar 

  30. Schmoeckel C, Stolz W, Sakai LY et al. Structure of basement membranes in malignant melanoma and nevocytic nevi. J Invest Dermatol 1989; 92: 663–8.

    Article  PubMed  CAS  Google Scholar 

  31. Somersalo K, Saksela E. Fibronectin facilitates the migration of human natural killer cells. Eur J Immunol 1991; 21: 35–42.

    PubMed  CAS  Google Scholar 

  32. Thomas C, Nijenhuis AM, Timens W et al. Liver metastasis model of colon cancer in the rat: Immunohistochemical characterization. Invasion and Metastasis 1993; 13: 102–12.

    CAS  Google Scholar 

  33. Unger ML, Johansson BR, Nannmark U. activated natural killer cells in vitro: Influence of extracellular matrix proteins. APMIS 1996; 104: 840–7.

    Article  PubMed  CAS  Google Scholar 

  34. Van Ravenswaay Claasen HH, Kluin PM, Fleuren GJ. Tumor in-filtrating cells in human cancer: On the possible role of CD16+ macrophages in antitumor cytotoxicity. Lab Invest 1992; 67: 166–74.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hagenaars, M., Ensink, N.G., Basse, P.H. et al. The microscopic anatomy of experimental rat CC531 colon tumour metastases: Consequences for immunotherapy?. Clin Exp Metastasis 18, 189–196 (2000). https://doi.org/10.1023/A:1006774602360

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1006774602360

Navigation